Maintaining daily consistency is vital for optimal results with oral semaglutide
Weight loss cellulite trapped in pockets may remain 11
Study 1: STEP-1 Trial (Obesity) Published in The New England Journal of Medicine , the STEP-1 trial found that adults with obesity or overweight who received weekly semaglutide injections lost an average of about 15% of their body weight over 68 weeks, compared with just 2.4% in the placebo group
Nevertheless, individuals with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN2) should seek specialist advice before using any drug in this class
Buynak, Internal Medicine Specialist See how people who had given up succeeded on GOLO
Scheperjans F, Aho V, Pereira PA, Koskinen K, Paulin L, Pekkonen E, et al